Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Plo

Showing results (101-110 of 124) with videos related to

Pageof 13
Sort By:
Nature Communications|November 28, 2017
Critical role of the HDAC6-cortactin axis in human megakaryocyte maturation leading to a proplatelet-formation defectKahia Messaoudi, Ashfaq Ali, Rameez Ishaq, et al.
Haematologica|March 6, 2025
Increased RhoA pathway activation downstream of αIIbβ3/SRC contributes to heterozygous Bernard Soulier syndromeLarissa Lordier, Christian A Di Buduo, Alexandre Kauskot, et al.
Haematologica|February 16, 2023
ANKRD26 is a new regulator of type I cytokine receptor signaling in normal and pathological hematopoiesisFrancesca Basso-Valentina, Alessandro Donada, Vladimir T Manchev, et al.
Blood Cancer Journal|November 5, 2025
Telomere occupancy by TRF2 is altered by KIT mutations and correlates with mastocytosis regressionJulie Bruneau, Sophie Georgin-Lavialle, Sophia Ladraa, et al.
Oncogene|June 24, 2020
Different impact of calreticulin mutations on human hematopoiesis in myeloproliferative neoplasmsMira El-Khoury, Xénia Cabagnols, Matthieu Mosca, et al.
The New England Journal of Medicine|May 29, 2009
Mutation in TET2 in myeloid cancersFrançois Delhommeau, Sabrina Dupont, Véronique Della Valle, et al.
Nature Communications|April 14, 2018
HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosisMargaux Sevin, Lucia Kubovcakova, Nicolas Pernet, et al.
Blood Advances|February 22, 2024
Exacerbation of thromboinflammation by JAK2V617F mutation worsens the prognosis of cerebral venous sinus thrombosisMarie-Charlotte Bourrienne, Véronique Le Cam Duchez, Dorothée Faille, et al.
The Journal of Clinical Investigation|May 19, 2022
Stepwise GATA1 and SMC3 mutations alter megakaryocyte differentiation in a Down syndrome leukemia modelBrahim Arkoun, Elie Robert, Fabien Boudia, et al.
Cancer Cell|July 5, 2011
TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesisCyril Quivoron, Lucile Couronné, Véronique Della Valle, et al.
Pageof 13

Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
Nature Communications|November 28, 2017
Critical role of the HDAC6-cortactin axis in human megakaryocyte maturation leading to a proplatelet-formation defectKahia Messaoudi, Ashfaq Ali, Rameez Ishaq, et al.
Haematologica|March 6, 2025
Increased RhoA pathway activation downstream of αIIbβ3/SRC contributes to heterozygous Bernard Soulier syndromeLarissa Lordier, Christian A Di Buduo, Alexandre Kauskot, et al.
Haematologica|February 16, 2023
ANKRD26 is a new regulator of type I cytokine receptor signaling in normal and pathological hematopoiesisFrancesca Basso-Valentina, Alessandro Donada, Vladimir T Manchev, et al.
Blood Cancer Journal|November 5, 2025
Telomere occupancy by TRF2 is altered by KIT mutations and correlates with mastocytosis regressionJulie Bruneau, Sophie Georgin-Lavialle, Sophia Ladraa, et al.
Oncogene|June 24, 2020
Different impact of calreticulin mutations on human hematopoiesis in myeloproliferative neoplasmsMira El-Khoury, Xénia Cabagnols, Matthieu Mosca, et al.
The New England Journal of Medicine|May 29, 2009
Mutation in TET2 in myeloid cancersFrançois Delhommeau, Sabrina Dupont, Véronique Della Valle, et al.
Nature Communications|April 14, 2018
HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosisMargaux Sevin, Lucia Kubovcakova, Nicolas Pernet, et al.
Blood Advances|February 22, 2024
Exacerbation of thromboinflammation by JAK2V617F mutation worsens the prognosis of cerebral venous sinus thrombosisMarie-Charlotte Bourrienne, Véronique Le Cam Duchez, Dorothée Faille, et al.
The Journal of Clinical Investigation|May 19, 2022
Stepwise GATA1 and SMC3 mutations alter megakaryocyte differentiation in a Down syndrome leukemia modelBrahim Arkoun, Elie Robert, Fabien Boudia, et al.
Cancer Cell|July 5, 2011
TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesisCyril Quivoron, Lucile Couronné, Véronique Della Valle, et al.
Pageof 13